---
title: "GINWA: Jintian Ge capsules approved for extended protection period of national traditional Chinese medicine protection varieties"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238223185.md"
description: "GINWA announced that the National Medical Products Administration has approved the extension of the secondary protection period for its Jintian Ge capsules under the national protection of traditional Chinese medicine to February 25, 2032. This medication is used to improve symptoms such as lower back pain, and the extension of the protection period will enhance the company's core competitiveness in the orthopedic field, positively impacting its production and operations"
datetime: "2025-04-30T07:57:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238223185.md)
  - [en](https://longbridge.com/en/news/238223185.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238223185.md)
---

# GINWA: Jintian Ge capsules approved for extended protection period of national traditional Chinese medicine protection varieties

According to the Zhitong Finance APP, GINWA (600080.SH) announced that recently, the National Medical Products Administration (hereinafter referred to as the NMPA) published the "Announcement on the Protection of Traditional Chinese Medicine Varieties (Extension of Protection Period No. 22) (2025 No. 44)", approving the continuation of secondary protection for the company's Jintian Ge capsules as a national traditional Chinese medicine variety.

The drug's main function is to strengthen bones. It is used to improve symptoms such as lower back pain, weakness in the waist and knees, weakness in the lower limbs, and difficulty walking. The NMPA's approval to continue granting secondary protection for the company's Jintian Ge capsules, extending the protection period to February 25, 2032, will help enhance the core competitiveness of the company's products in the orthopedic field and have a positive impact on the company's production and operations

### Related Stocks

- [600080.CN](https://longbridge.com/en/quote/600080.CN.md)
- [562390.CN](https://longbridge.com/en/quote/562390.CN.md)

## Related News & Research

- [Lumentum Stock Analysis: Buy or Sell?](https://longbridge.com/en/news/287135328.md)
- ['Govt in advanced stage of consultation on cotton import duty removal'](https://longbridge.com/en/news/287449163.md)
- [Xiaomi CEO says new YU7 GT SUV will be 'a bit expensive'](https://longbridge.com/en/news/287017686.md)
- [BYD is struggling to meet demand for new fast-charging EVs as orders reach 100K, 60K](https://longbridge.com/en/news/287109883.md)
- [15:49 ETElectrolux Group announces terms for the fully underwritten rights issue of SEK 9,062 million](https://longbridge.com/en/news/287265039.md)